NASDAQ:NYXH

Nyxoah (NYXH) Stock Price, News & Analysis

Nyxoah logo
$0.89 -0.01 (-0.64%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$0.90 +0.01 (+0.82%)
As of 11/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Nyxoah Stock (NASDAQ:NYXH)

Advanced

Key Stats

Today's Range
$0.88
▼
$0.90
50-Day Range
$0.81
▼
$1.60
52-Week Range
$0.80
▼
$5.39
Volume
61,812 shs
Average Volume
285,713 shs
Market Capitalization
$34.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.55
Consensus Rating
Hold

Company Overview

Nyxoah is a medical technology company focused on treatments for obstructive sleep apnea (OSA), a condition in which breathing repeatedly stops or becomes shallow during sleep. The company develops implantable neurostimulation systems for patients who cannot use or do not benefit from conventional therapies such as continuous positive airway pressure.

Its lead product, the Genio system, stimulates the hypoglossal nerve to help keep the tongue from obstructing the airway during sleep. The system uses an implanted stimulator and an external wearable component, and is designed to stimulate both sides of the nerve.

Founded in Belgium, Nyxoah received European CE marking for Genio in 2019 and has pursued commercialization in markets where the system is authorized. The company is headquartered in Mont-Saint-Guibert, Belgium, and is led by Chief Executive Officer Olivier Taelman.

AI Generated. May Contain Errors.

Nyxoah Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
67th Percentile Overall Score

NYXH MarketRank™: 
3.372263747995 of 5 stars

Nyxoah scored higher than 67% of companies evaluated by MarketBeat, and ranked 385th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nyxoah has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Nyxoah has a consensus price target of $3.55, representing about 297.4% upside from its current price of $0.89.

  • Amount of Analyst Coverage

    Nyxoah has only been the subject of 2 research reports in the past 90 days.

  • Read more about Nyxoah's stock forecast and price target.
  • Earnings Growth

    Earnings for Nyxoah are expected to grow in the coming year, from ($1.40) to ($0.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nyxoah is -0.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nyxoah is -0.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nyxoah has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.85% of the float of Nyxoah has been sold short.
  • Short Interest Ratio / Days to Cover

    Nyxoah has a short interest ratio ("days to cover") of 0.98, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nyxoah has recently increased by 55.10%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nyxoah does not currently pay a dividend.

  • Dividend Growth

    Nyxoah does not have a long track record of dividend growth.

  • News Sentiment

    Nyxoah has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Nyxoah this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for NYXH on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Nyxoah to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nyxoah insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Nyxoah has minimal institutional ownership at this time.

  • Read more about Nyxoah's insider trading history.
Receive NYXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NYXH Stock News Headlines

Nyxoah SA (NASDAQ:NYXH) Sees Large Increase in Short Interest
Nyxoah (NASDAQ:NYXH) Upgraded at Wall Street Zen
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel
Nyxoah Earnings Call Highlights Growth and Guidance Reset
Nyxoah (NYXH) Q3 2026 Earnings Call Transcript
Nyxoah SA (NYXH) Q3 2026 Earnings Call Transcript
Nyxoah Reports Third Quarter 2026 Financial and Operating Results
See More Headlines

NYXH Stock Analysis - Frequently Asked Questions

Nyxoah's stock was trading at $4.60 at the start of the year. Since then, NYXH stock has decreased by 80.6% and is now trading at $0.8937.

Nyxoah SA (NASDAQ:NYXH) released its quarterly earnings data on Thursday, November, 5th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.04. The company earned $10.39 million during the quarter, compared to analysts' expectations of $11.45 million. Nyxoah had a negative trailing twelve-month return on equity of 153.98% and a negative net margin of 313.03%.
Read the conference call transcript
.

Nyxoah (NYXH) raised $83 million in an IPO on Friday, July 2nd 2021. The company issued 2,760,000 shares at a price of $30.00 per share.

Nyxoah's top institutional shareholders include AIGH Capital Management LLC (37.75%) and Goldman Sachs Group Inc. (0.06%).

Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nyxoah investors own include CoreWeave (CRWV), Digital Brands Group (DBGI), IREN (IREN), MDxHealth (MDXH), monday.com (MNDY), NVIDIA (NVDA) and Plug Power (PLUG).

Company Calendar

Last Earnings
11/05/2026
Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:NYXH
CIK
1857190
Employees
154
Year Founded
2008

Price Target and Rating

High Price Target
$6.00
Low Price Target
$2.31
Potential Upside/Downside
+297.4%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.98)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$101.92 million
Net Margins
-313.03%
Pretax Margin
-310.88%
Return on Equity
-153.98%
Return on Assets
-68.17%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
2.19
Quick Ratio
2.08

Sales & Book Value

Annual Sales
$11.33 million
Price / Sales
3.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.02 per share
Price / Book
0.44

Miscellaneous

Outstanding Shares
38,760,000
Free Float
N/A
Market Cap
$34.64 million
Optionable
Not Optionable
Beta
1.80

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:NYXH) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners